Progenity Stock Is a Zero-or-Hero Holding for Biotech Bidders Posted byDavid Moadel October 11, 2021 Leave a comment on Progenity Stock Is a Zero-or-Hero Holding for Biotech Bidders On the heels of a potent patent, short-squeeze target Progenity (PROG) offers excitement – and just maybe, outsized gains – for bold speculators.